PGR and breast carcinoma: Recently, a comprehensive immunohistochemistry (IHC) study by Kurebayashi et al. showed that SHH expression was positively correlated with tumor size, Ki-67 labeling index, and HER2 positivity, but negatively correlated with estrogen receptor (ER+) and progesterone receptor (PR+) breast cancer [220].